본문 바로가기

High-Throughput 3D Bioprinted Organoids of Skin Cancer Utilized for Diagnosis and Personalized Therapy

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q2
저널
CURRENT ONCOLOGY32(12) · #653 · 2025
피인용
Web of Science 7Scopus 9
FWCI (Scopus)
0.87
JCR IF
JCR 2024 3.4
ISSN
1198-0052

저자

  1. 아르빈드 쿠마르 수클라제1저자교신저자Pusan Natl Univ, Sch Biomed Convergence Engn, Yangsan 50612, South Korea
  2. Shukla, SandhyaBharati Vidyapeeth Deemed Univ, Med Coll, Dept Pharmacol, Pune 411043, India
  3. Suryawanshi, Sonali PradeepBharati Vidyapeeth Deemed Univ, Med Coll, Dept Pharmacol, Pune 411043, India
  4. Upadhyay, Adarsha MahendraGuizhou Med Univ, Sch Overseas Educ, Dept Gastrointestinal Surg, Guiyang 550025, Peoples R China
  5. 레이나빈Pusan Natl Univ, Dept Integrat Biomed Sci, Lab Mucosal Exposome & Biomodulat, Yangsan 50612, South Korea
  6. 고빈단 티루파티Pusan Natl Univ, Dept Integrat Biomed Sci, Lab Mucosal Exposome & Biomodulat, Yangsan 50612, South Korea
  7. Dutta, Sayan DebKangwon Natl Univ, Dept Biosyst Engn, Chunchon 24341, South Korea
  8. Mongre, Raj Kumar교신저자Harvard Univ, Boston Childrens Hosp, Harvard Med Sch, Dept Surg, 300 Longwood Ave, Boston, MA 02115 USA

초록

Recent advancements in three-dimensional (3D) bioprinting have revolutionized the modeling of skin cancer, enabling the fabrication of high-throughput, patient-specific organoids that recapitulate the structural, functional, and microenvironmental complexity of native tumors. This review focuses on the integration of cutting-edge bioprinting technologies with bioengineered extracellular matrices and patient-derived cells to generate physiologically relevant skin cancer models for diagnostic and personalized medicine applications. Key technological innovations, including novel bioinks, multi-material printing strategies, and biomimetic approaches, are discussed for their ability to replicate tumor-stroma interactions, vascularization, and immune microenvironments. The utility of bioprinted organoids in high-throughput drug screening, mutation-targeted therapy design, and biomarker discovery is critically evaluated. Additionally, we address current challenges in standardization, reproducibility, and clinical translation, highlighting regulatory and quality-control considerations. Collectively, this review emphasizes the transformative potential of 3D bioprinted skin cancer organoids as platforms for precision oncology, bridging bioengineering advances with translational research to accelerate therapeutic development and personalized treatment strategies.

키워드

3D bioprintingskin cancer organoidshigh-throughput screeningpersonalized therapytumor microenvironmentprecision oncologyON-A-CHIPMODELSMICROENVIRONMENTKERATINOCYTESHETEROGENEITYTECHNOLOGIESFIBROBLASTSCHALLENGESDISCOVERYMIGRATION

식별자

Scopus EID
2-s2.0-105025738834
WoS UID
001646211700001